| Literature DB >> 24860280 |
C Malarkodi1, S Rajeshkumar1, K Paulkumar1, M Vanaja1, G Gnanajobitha1, G Annadurai1.
Abstract
Dental care is an essential phenomenon in human health. Oral pathogens can cause severe break which may show the way to serious issues in human disease like blood circulation and coronary disease. In the current study, we demonstrated the synthesis and antimicrobial activity of cadmium sulphide and zinc sulphide nanoparticles against oral pathogens. The process for the synthesis of cadmium sulphide (CdS) and zinc sulphide (ZnS) nanoparticles is fast, novel, and ecofriendly. Formation of cadmium sulphide (CdS) and zinc sulphide (ZnS) nanoparticles was confirmed by surface plasmon spectra using UV-Vis spectrophotometer. The morphology of crystalline phase of nanoparticles was determined from transmission electron microscopy (TEM) and X-ray diffraction (XRD) spectra. The average size of cadmium sulphide (CdS) and zinc sulphide (ZnS) nanoparticles was in the range of 10 nm to 25 nm and 65 nm, respectively, and the observed morphology was spherical. The results indicated that the proteins, which contain amine groups, played a reducing and controlling responsibility during the formation of cadmium sulphide (CdS) and zinc sulphide (ZnS) nanoparticles in the colloidal solution. The antimicrobial activity was assessed against oral pathogens such as Streptococcus sp. Staphylococcus sp. Lactobacillus sp., and Candida albicans and these results confirmed that the sulphide nanoparticles are exhibiting good bactericidal activity.Entities:
Year: 2014 PMID: 24860280 PMCID: PMC4016845 DOI: 10.1155/2014/347167
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 1Biosynthesis of CdS and ZnS nanoparticles: (a) and (c) culture supernatant, (b) and (d) with addition of metal ions 24-hour incubation.
Figure 2Absorption spectrum of nanoparticles synthesized by the culture supernatant of K. pneumoniae and SPR band at 420 nm for CdS (a) and 400 nm for ZnS (b).
Figure 3XRD pattern of sulfide nanoparticles synthesized by K. pneumoniae: (a) CdS and (b) ZnS.
Figure 4TEM image of synthesized sulfide nanoparticle by K. pneumoniae: (a) CdS and (b) ZnS, and SAED pattern of sulfide nanoparticle: (c) CdS and (d) ZnS.
Figure 5FTIR spectra recorded from powder of sulfide nanoparticles synthesized using K. pneumoniae: (a) CdS and (b) ZnS.
Figure 6Probable pathway of biosynthesis and stability of biofunctionalized sulfide nanoparticle.
Figure 7Fluorescence image of (a) CdS nanoparticles and (b) ZnS nanoparticles synthesized from K. pneumoniae.
Zone of CdS nanoparticles against oral pathogenic microorganisms.
| Concentration of cadmium sulfide nanoparticles | Zone of inhibition (mm in diameter) | |||
|---|---|---|---|---|
|
|
|
|
| |
| 100 | 15.66 ± 0.40 | 16.66 ± 0.42 | 10.66 ± 0.95 | 11.66 ± 0.44 |
| 200 | 18.33 ± 0.46 | 19.33 ± 0.5 | 12.66 ± 0.27 | 15.33 ± 0.32 |
| 300 | 26.33 ± 0.63 | 25.33 ± 6.42 | 15 ± 3.27 | 17.66 ± 4.32 |
±Standard deviation.
Antimicrobial activity of ZnS nanoparticles against oral pathogens.
| Concentration of zinc sulfide nanoparticles | Zone of inhibition (mm in diameter) | |||
|---|---|---|---|---|
|
|
|
|
| |
| 100 | 15.33 ± 0.41 | 15.33 ± 0.32 | 9.66 ± 0.47 | 12.33 ± 0.43 |
| 150 | 17.66 ± 0.44 | 18.33 ± 0.47 | 14.33 ± 0.38 | 16 ± 0.22 |
| 200 | 24.33 ± 0.18 | 25.66 ± 0.60 | 16.66 ± 0.42 | 18.66 ± 0.65 |
±Standard deviation.